RetractedArticleBioengineered2022

Salvianolic acid A (Sal A) suppresses malignant progression of glioma and enhances temozolomide (TMZ) sensitivity via repressing transgelin-2 (TAGLN2) mediated phosphatidylinositol-3-kinase (PI3K) / protein kinase B (Akt) pathway.

Tingting Ye et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.